Company / SG&A per Share
Cyclerion Therapeutics, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.39
FY2025
5-year range
$0.30 / $5.91
FY2021-FY2025
Trend
-27.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $5.91 to $2.39 over the past 2 years.
Based on SEC 10-K filings.
2.39 in FY2025 with a 5-year CAGR of +13.9%.
Improved from $5.91 to $2.39 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +100.6%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 27.2% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.39 | -27.2% |
| FY2024 | $3.29 | -44.4% |
| FY2023 | $5.91 | +1895.0% |
| FY2022 | $0.30 | -68.7% |
| FY2021 | $0.95 | -24.0% |
| FY2020 | $1.25 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026